| __timestamp | Corcept Therapeutics Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 301600000 |
| Thursday, January 1, 2015 | 50286000 | 293461000 |
| Friday, January 1, 2016 | 81321000 | 301853000 |
| Sunday, January 1, 2017 | 159201000 | 331378000 |
| Monday, January 1, 2018 | 251247000 | 343374000 |
| Tuesday, January 1, 2019 | 306486000 | 347337000 |
| Wednesday, January 1, 2020 | 353874000 | 339410000 |
| Friday, January 1, 2021 | 365978000 | 425208000 |
| Saturday, January 1, 2022 | 401858000 | 935061000 |
| Sunday, January 1, 2023 | 482375000 | 1296429000 |
Cracking the code
In the ever-evolving landscape of the pharmaceutical industry, Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated have demonstrated remarkable revenue growth over the past decade. From 2014 to 2023, Lantheus Holdings has seen its annual revenue surge by over 330%, reaching a peak in 2023. This impressive growth trajectory highlights the company's strategic advancements and market adaptability.
Conversely, Corcept Therapeutics has also experienced significant growth, with its revenue increasing by approximately 1,700% during the same period. This growth underscores Corcept's successful expansion and innovation in the field of endocrinology.
While both companies have shown robust financial performance, Lantheus Holdings consistently outpaced Corcept Therapeutics in terms of revenue, particularly in recent years. This comparison offers valuable insights into the competitive dynamics and strategic positioning within the pharmaceutical sector.
Revenue Insights: Eli Lilly and Company and Corcept Therapeutics Incorporated Performance Compared
Novo Nordisk A/S vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Corcept Therapeutics Incorporated
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
Revenue Showdown: Viatris Inc. vs Corcept Therapeutics Incorporated
Revenue Insights: Catalent, Inc. and Corcept Therapeutics Incorporated Performance Compared
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: Lantheus Holdings, Inc. vs Novavax, Inc.
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?
Corcept Therapeutics Incorporated or Galapagos NV: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics